Evidence map›Paper›PMID 36051222›Full record

ReviewFrontiers in neurology2022

Molecular imaging biomarkers in familial frontotemporal lobar degeneration: Progress and prospects.

Ruihan Wang, Hui Gao, Hongsheng Xie, Zhiyun Jia, Qin Chen

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ruihan WangDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Hui GaoDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Hongsheng XieDepartment of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, China.
Zhiyun JiaDepartment of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, China.
Qin ChenDepartment of Neurology, West China Hospital of Sichuan University, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial frontotemporal lobar degeneration (FTLD) is a pathologically heterogeneous group of neurodegenerative diseases with diverse genotypes and clinical phenotypes. Three major mutations were reported in patients with familial FTLD, namely, progranulin (

Indexed as

biomarkersC9orf72familial frontotemporal lobar degenerationGRNMAPTmolecular imaging

Identifiers

PMID36051222
PMCPMC9424494
OpenAlexW4291916411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.